返回 Agenda
Session Chair(s)
Nigel R. Richardson, PHD
Head Analytical Technology & Automation, CMC Analytical
GlaxoSmithKline, United Kingdom
Speaker(s)
Advances in Analytical Approaches to Impurity Control for Commercial Oligonucleotides
Mike L. Webb
GlaxoSmithKline, United Kingdom
Vice President, API Chemistry & Analysis
Panelist
Mike L. Webb
GlaxoSmithKline, United Kingdom
Vice President, API Chemistry & Analysis
Rao Kambhampati, PHD
FDA, United States
Senior Chemist, CDER
René Thürmer, PHD
Federal Institute for Drugs and Medical Devices, Germany
Quality Assessor
Christoph Rosenbohm, PHD, MBA
Roche Innovation Center Copenhagen, Denmark
Vice President, Head of Discovery Operations